SOUTH SAN FRANCISCO, Calif., March 13 SunesisPharmaceuticals, Inc. (Nasdaq: SNSS) today announced that Daniel Swisher,Sunesis' Chief Executive Officer and President, will provide a corporateoverview at two upcoming investor conferences in March.
Interested parties may access a webcast of each the presentations byvisiting the Sunesis website at http://ir.sunesis.com. A replay of thewebcasts will be archived on the "Calendar of Events" page in the Investorsand Media section of the Sunesis website for two weeks.
About Sunesis Pharmaceuticals
Sunesis is a clinical-stage biopharmaceutical company focused on thediscovery, development and commercialization of novel small-moleculetherapeutics for oncology and other serious diseases. Sunesis has built abroad product candidate portfolio through internal discovery and in-licensingof novel cancer therapeutics. Sunesis is advancing its product candidatesthrough in-house research and development efforts and strategic collaborationswith leading pharmaceutical and biopharmaceutical companies. For furtherinformation on Sunesis Pharmaceuticals, please visit http://www.sunesis.com.-- Mr. Swisher will speak at the Cowen and Company 28th Annual Health Care Conference at 8:45 a.m. Eastern Time on Tuesday, March 18, 2008 at the Boston Marriott Copley Place in Boston, Mass. -- On Thursday, March 20, 2008, Mr. Swisher will present at the Lehman Brothers Eleventh Annual Global Healthcare Conference at 12:45 p.m. Eastern Time in Miami, Fla.
SOURCE Sunesis Pharmaceuticals, Inc.